Current state and future prospects of immunotherapy for glioma | ||
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas | |
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | University of Michigan | |
| dc.conicet.organizacion | University of Michigan | |
| dc.contributor.author | Kamran, Neha | |
| dc.contributor.author | Alghamri, Mahmoud S. | |
| dc.contributor.author | Nunez, Felipe J. | |
| dc.contributor.author | Shah, Diana | |
| dc.contributor.author | Asad, Antonela Sofía | |
| dc.contributor.author | Candolfi, Marianela | |
| dc.contributor.author | Altshuler, David | |
| dc.contributor.author | Lowenstein, Pedro R. | |
| dc.contributor.author | Castro, Maria G. | |
| dc.date.issued | 2018-03 | |
| dc.description.abstract | There is a large unmet need for effective therapeutic approaches for glioma, the most malignant brain tumor. Clinical and preclinical studies have enormously expanded our knowledge about the molecular aspects of this deadly disease and its interaction with the host immune system. In this review we highlight the wide array of immunotherapeutic interventions that are currently being tested in glioma patients. Given the molecular heterogeneity, tumor immunoediting and the profound immunosuppression that characterize glioma, it has become clear that combinatorial approaches targeting multiple pathways tailored to the genetic signature of the tumor will be required in order to achieve optimal therapeutic efficacy. | es |
| dc.description.fil | Fil: Kamran, Neha. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Alghamri, Mahmoud S.. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Nunez, Felipe J.. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Shah, Diana. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Asad, Antonela Sofía. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas; Argentina | |
| dc.description.fil | Fil: Candolfi, Marianela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas; Argentina | |
| dc.description.fil | Fil: Altshuler, David. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Lowenstein, Pedro R.. University of Michigan; Estados Unidos | |
| dc.description.fil | Fil: Castro, Maria G.. University of Michigan; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Kamran, Neha; Alghamri, Mahmoud S.; Nunez, Felipe J.; Shah, Diana; Asad, Antonela Sofía; et al.; Current state and future prospects of immunotherapy for glioma; Future Medicine; Immunotherapy; 10; 4; 3-2018; 317-339 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1750-743X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/86972 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 4 | es |
| dc.journal.pagination | 317-339 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Immunotherapy | es |
| dc.journal.volume | 10 | es |
| dc.language.iso | eng | es |
| dc.publisher | Future Medicine | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.futuremedicine.com/doi/10.2217/imt-2017-0122 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.2217/imt-2017-0122 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | CANCER VACCINES | es |
| dc.subject | CHECKPOINT BLOCKADE | es |
| dc.subject | GENE THERAPY | es |
| dc.subject | GLIOMA | es |
| dc.subject | IMMUNOTHERAPY | es |
| dc.subject | PASSIVE IMMUNOTHERAPY | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Current state and future prospects of immunotherapy for glioma | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.1c64b97c-bb57-43b0-81e5-67c8a3ae2d91_A.pdf
- Tamaño:
- 1.73 MB
- Formato:
- Adobe Portable Document Format